Gene · 369
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Copper-Dependent Kinases and Their Role in Cancer Inception, Progression and Metastasis. | Biomolecules | 2022 | 36291728 | PubTator, text mining | PubMed |
| The Tumour Suppressor Fhit Protein Activates C-Raf Ubiquitination and Degradation in Human Melanoma Cells by Interacting with Hsp90. | Biomedicines | 2022 | 36289813 | PubTator, text mining | PubMed |
| ERK1/2 in immune signalling. | Biochem Soc Trans | 2022 | 36281999 | PubTator, text mining | PubMed |
| Novel thiazole derivatives incorporating phenyl sulphonyl moiety as potent BRAFV600E kinase inhibitors targeting melanoma. | RSC Adv | 2022 | 36276003 | PubTator, text mining | PubMed |
| 4-Carbomethoxyl-10-Epigyrosanoldie E Extracted from Cultured Soft Coral Sinularia sandensis Induced Apoptosis and Autophagy via ROS and Mitochondrial Dysfunction and ER Stress in Oral Cancer Cells. | Oxid Med Cell Longev | 2022 | 36275891 | PubTator, text mining | PubMed |
| Scaffold proteins as dynamic integrators of biological processes. | J Biol Chem | 2022 | 36273588 | PubTator, text mining | PubMed |
| Comparative and evolutionary analysis of RIP kinases in immune responses. | Front Genet | 2022 | 36263437 | PubTator, text mining | PubMed |
| Overview of predictive and prognostic biomarkers and their importance in developing a clinical pharmacology treatment plan in colorectal cancer patients. | Expert Rev Clin Pharmacol | 2022 | 36259230 | PubTator, text mining | PubMed |
| Small molecule inhibitors targeting the cancers. | MedComm (2020) | 2022 | 36254250 | PubTator, text mining | PubMed |
| HERC2 deficiency activates C-RAF/MKK3/p38 signalling pathway altering the cellular response to oxidative stress. | Cell Mol Life Sci | 2022 | 36241744 | PubTator, text mining | PubMed |
| Potential of Kalanchoe pinnata as a Cancer Treatment Adjuvant and an Epigenetic Regulator. | Molecules | 2022 | 36234962 | PubTator, text mining | PubMed |
| Head-to-Head Comparison of BRAF/MEK Inhibitor Combinations Proposes Superiority of Encorafenib Plus Trametinib in Melanoma. | Cancers (Basel) | 2022 | 36230853 | PubTator, text mining | PubMed |
| BRAF Inhibitors in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2022 | 36230797 | PubTator, text mining | PubMed |
| MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. | Cancers (Basel) | 2022 | 36230547 | PubTator, text mining | PubMed |
| Molecular targeted therapy for anticancer treatment. | Exp Mol Med | 2022 | 36224343 | PubTator, text mining | PubMed |
| Signaling pathways and therapeutic interventions in gastric cancer. | Signal Transduct Target Ther | 2022 | 36209270 | PubTator, text mining | PubMed |
| Potential role of MAP2K1 mutation in the trans-differentiation of interdigitating dendritic cell sarcoma: Case report and literature review. | Front Pediatr | 2022 | 36186629 | PubTator, text mining | PubMed |
| A novel acidic polysaccharide from blackened jujube: Structural features and antitumor activity in vitro. | Front Nutr | 2022 | 36185697 | PubTator, text mining | PubMed |
| How to read a next-generation sequencing report-what oncologists need to know. | ESMO Open | 2022 | 36183443 | PubTator, text mining | PubMed |
| BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies. | Curr Treat Options Oncol | 2022 | 36181568 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/369/papers?page=19